Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC
type: MedicalStudy
description: International Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial Evaluating Efficacy and Safety Of BCD-100 in Combination With Pemetrexed+Cisplatin/Carboplatin Compared to Placebo in Combination With Pemetrexed+Cisplatin/Carboplatin as First-Line Treatment of Subjects With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)
status: UNKNOWN
study design: INTERVENTIONAL
phase: PHASE3
start date: 2019-06-01
end date: 2023-12
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT03912389
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Biocad
study subject: Non-Squamous Non-Small Cell Neoplasm of Lung
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: UNKNOWN
keywords: Non-Squamous Non-Small Cell Neoplasm of Lung

AI Analytics
type: Organization